RERAX
Price
$59.26
Change
-$1.78 (-2.92%)
Updated
Feb 3 closing price
Net Assets
134.63B
RIVDX
Price
$20.65
Change
+$0.65 (+3.25%)
Updated
Feb 3 closing price
Net Assets
2.57B
Interact to see
Advertisement

RERAX vs RIVDX

Header iconRERAX vs RIVDX Comparison
Open Charts RERAX vs RIVDXBanner chart's image
American Funds EUPAC R1
Price$59.26
Change-$1.78 (-2.92%)
VolumeN/A
Net Assets134.63B
American Funds International Vntg R-2
Price$20.65
Change+$0.65 (+3.25%)
VolumeN/A
Net Assets2.57B
RERAX vs RIVDX Comparison Chart in %
View a ticker or compare two or three
VS
RERAX vs. RIVDX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERAX is a Buy and RIVDX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 135B vs. RIVDX (2.57B). RERAX pays higher dividends than RIVDX: RERAX (2.30) vs RIVDX (0.63). RERAX was incepted earlier than RIVDX: RERAX (24 years) vs RIVDX (6 years). RIVDX (1.61) and RERAX (1.57) have similar cost to investors . RERAX is a more actively managed with annual turnover of: 35.00 vs. RIVDX (32.00). RERAX (250) and RIVDX (250) have matching initial minimum investment requirements. RIVDX annual gain was more profitable for investors over the last year : 24.78 vs. RERAX (16.59). RIVDX return over 5 years is better than : 28.68 vs. RERAX (-8.55).
RERAXRIVDXRERAX / RIVDX
Total Expense Ratio1.571.6098%
Annual Report Gross Expense Ratio1.571.6198%
Fund Existence24 years6 years-
Gain YTD5.5763.926142%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets135B2.57B5,247%
Annual Yield % from dividends2.300.63362%
Returns for 1 year16.5924.7867%
Returns for 3 years21.4337.3257%
Returns for 5 years-8.5528.68-30%
Returns for 10 years56.65N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EEMRX10.850.09
+0.84%
MFS Emerging Markets Equity Research C
OLVAX22.810.02
+0.09%
JPMorgan Large Cap Value A
BGPKX1.93N/A
N/A
Baillie Gifford Developed EAFE All Cap K
GGFRX15.43-0.14
-0.90%
Nationwide BNY Mellon Dyn US Core R
JFAIX35.47-0.71
-1.96%
JHancock Fundamental All Cap Core R6